atai Life Sciences (ATAI) News Today $5.54 +0.07 (+1.28%) Closing price 04:00 PM EasternExtended Trading$5.58 +0.04 (+0.81%) As of 05:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATAI Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Cathie Wood’s ARK Investment buys 254.6K shares of Atai Life Sciences todayOctober 7 at 7:48 AM | msn.comatai Life Sciences' Glenn Short discusses the company's NIH grant and innovative discovery program – ICYMIOctober 3, 2025 | proactiveinvestors.comatai Life Sciences' Glenn Short discusses the company's NIH grant and innovative discovery program – ICYMIOctober 3, 2025 | proactiveinvestors.comWhy Atai Life Sciences (ATAI) Is in Focus After Positive Depression Data and $239M Shelf Registration FilingOctober 2, 2025 | finance.yahoo.comAtai Life Sciences: Still A Decent Prospect - But Only JustOctober 1, 2025 | seekingalpha.comAtai Life Sciences files automatic mixed securities shelfSeptember 29, 2025 | msn.comAtai Life Sciences files to sell 45.32M common shares for holdersSeptember 29, 2025 | msn.comatai and Beckley’s psychedelic advances to pivotal TRD trialSeptember 24, 2025 | msn.comDemystifying ATAI Life Sciences: Insights From 5 Analyst ReviewsSeptember 23, 2025 | benzinga.comAtai Life Sciences N.V. (ATAI) Advances Psychedelic Therapies for Mental Health, Drawing Investor SpotlightSeptember 23, 2025 | msn.comatai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment ...September 23, 2025 | markets.businessinsider.comatai Life Sciences rises after promising data from depression trialSeptember 23, 2025 | msn.comatai shares jump 10% on positive trial data for depression nasal spraySeptember 23, 2025 | proactiveinvestors.comatai Life Sciences and Beckley Psytech report positive mid-stage trial results for depression treatmentSeptember 23, 2025 | proactiveinvestors.comatai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant DepressionSeptember 23, 2025 | globenewswire.comAtai Life Sciences (ATAI): How NIDA’s $11.4M Grant Shapes the Valuation OutlookSeptember 21, 2025 | finance.yahoo.comH.C. Wainwright Affirms ‘Buy’ Rating on Atai Life Sciences N.V. (ATAI) on Psychedelic ProspectsSeptember 20, 2025 | msn.comAtai Life Sciences awarded grant worth up to $11.4M from NIHSeptember 19, 2025 | msn.comatai Life Sciences Awarded Grant from the National Institutes of HealthSeptember 19, 2025 | finance.yahoo.comatai Life Sciences secures NIH grant for opioid use disorder programSeptember 18, 2025 | proactiveinvestors.comAtai Life Sciences N.V. (ATAI) Presents at H.C. Wainwright 27th Annual Global Investment Conference TranscriptSeptember 9, 2025 | seekingalpha.comAtai Life Sciences N.V. (ATAI)’s BPL-003 Achieves Robust Phase 2b Success in Treatment-Resistant DepressionSeptember 2, 2025 | finance.yahoo.comatai Life Sciences to Participate in September Investor ConferencesAugust 28, 2025 | globenewswire.comH.C. Wainwright Reiterates a Buy Rating on Atai Life Sciences (ATAI)August 26, 2025 | msn.comAtai Life Sciences Revenue Jumps 163%August 15, 2025 | theglobeandmail.comAtai Life Sciences Second Quarter 2025 Earnings: US$0.14 loss per share (vs US$0.36 loss in 2Q 2024)August 15, 2025 | uk.finance.yahoo.comAtai Life Sciences Reports Q2 2025 Financial ResultsAugust 15, 2025 | msn.comRL-007 Poised to Transform CIAS Market as First Targeted Therapy for Cognitive Deficits in Schizophrenia | DelveInsightAugust 14, 2025 | theglobeandmail.comatai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate UpdatesAugust 14, 2025 | finance.yahoo.comatai Life Sciences marks milestone quarter with key clinical wins, Beckley merger plansAugust 14, 2025 | proactiveinvestors.comMaxim Group Reiterates a Buy Rating on Atai Life Sciences (ATAI) With a $10 PTAugust 4, 2025 | msn.comH.C. Wainwright Lifts PT on Atai Life Sciences (ATAI) to $15 From $10July 31, 2025 | msn.comATAI Life Sciences (ATAI) Gets a Buy from TD CowenJuly 30, 2025 | theglobeandmail.comOppenheimer Initiates Coverage of Atai Life Sciences N.V. (ATAI) with Outperform RecommendationJuly 30, 2025 | msn.comAtai: Inidascamine Trial Failure Doesn't Matter In Main Psychedelic Pipeline FocusJuly 28, 2025 | seekingalpha.comAtai backs away from schizophrenia drug after trial failureJuly 28, 2025 | finance.yahoo.comATAI Life Sciences (ATAI) Stock Plunge on Trial Failure NewsJuly 28, 2025 | finance.yahoo.comatai eyes 2025 catalysts in psychedelic portfolio following Recognify trial updateJuly 28, 2025 | proactiveinvestors.comATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market SessionJuly 28, 2025 | benzinga.comRecognify’s Phase IIb trial of schizophrenia therapy fails to meet primary goalJuly 28, 2025 | finance.yahoo.comATAI Life Sciences stock falls after Recognify’s CIAS drug misses endpointJuly 26, 2025 | investing.comStocks to Watch: Atai Life Sciences, AmrepJuly 26, 2025 | marketwatch.comAtai Life Sciences' Stock Retreats After Recognify Schizophrenia Trial Misses EndpointJuly 26, 2025 | marketwatch.comAtai Life Sciences schizophrenia drug fails to meet main goal in trialJuly 26, 2025 | msn.comCanaccord Increases Atai Life Sciences (ATAI) PT, Keeps Buy RatingJuly 26, 2025 | insidermonkey.comAtai Life Sciences schizophrenia drug fails to meet main goal in mid-stage trialJuly 25, 2025 | reuters.comRecognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with SchizophreniaJuly 25, 2025 | globenewswire.comatai Life Sciences poised to lead treatment-resistant depression market with psychedelic candidateJuly 23, 2025 | proactiveinvestors.comSpravato sales momentum underscores market potential for psychedelics, atai Life Sciences seen as key beneficiaryJuly 18, 2025 | proactiveinvestors.comAegis Capital Reaffirms Buy on Atai Life Sciences N.V. (ATAI) with $8 TargetJuly 11, 2025 | finance.yahoo.com Get atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ATAI Media Mentions By Week ATAI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATAI News Sentiment▼1.000.55▲Average Medical News Sentiment ATAI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATAI Articles This Week▼53▲ATAI Articles Average Week Get the Latest News and Ratings for ATAI and Related Stocks Enter your email address to receive the latest news and analysts' ratings for atai Life Sciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies PTCT News Today ARWR News Today PCVX News Today ACLX News Today KYMR News Today CRNX News Today PTGX News Today AKRO News Today MENS News Today SRRK News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATAI) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding atai Life Sciences N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share atai Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
